How much does Amcinonide cost?

Pricing for Amcinonide varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Amcinonide need prior authorization?

Amcinonide appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Amcinonide?

We haven't verified an active copay card or PAP for Amcinonide in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Amcinonide used to treat?

Amcinonide (generic: Amcinonide) is indicated for Eczema, Corticosteroid-responsive dermatoses. Click any condition name on this page for more detail.

Amcinonide

Generic: Amcinonide

Verified·Apr 23, 2026

NDC: 73308-407
ICD-10 indication: L30.9

Affordability Check

How much will you actually pay for Amcinonide?

In 30 seconds, see every legitimate way to afford Amcinonide — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Amcinonide

What is this medication?

Amcinonide is a high-potency topical corticosteroid medication primarily used to treat various inflammatory skin conditions. It is effective in reducing symptoms such as redness, swelling, and severe itching that often accompany conditions like plaque psoriasis, atopic dermatitis, and allergic contact dermatitis. By suppressing the immune system localized inflammatory response, it provides relief for skin that has become irritated or inflamed due to chronic or acute triggers. This medication is typically reserved for cases that require more intensive treatment than over-the-counter options can provide.

The medication functions by preventing the release of substances in the body that cause inflammation. It is generally applied directly to the skin in the form of a cream, ointment, or lotion as prescribed by a healthcare provider. Because of its high potency, it is often recommended for short-term use to minimize the risk of side effects like skin thinning or irritation. Users should follow medical advice regarding where to apply the product, usually avoiding sensitive areas such as the face or underarms unless a doctor specifically authorizes its use there.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Amcinonide.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Amcinonide →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Amcinonide →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Amcinonide. Official source: DailyMed (NLM) · Label effective Oct 6, 2025

Indications and usage

INDICATIONS AND USAGE: Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage and administration

DOSAGE AND ADMINISTRATION: Topical corticosteroids are generally applied to the affected area as a thin film from two to three times daily depending on the severity of the condition. Occlusive dressings may be a valuable therapeutic adjunct for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Contraindications

CONTRAINDICATIONS: Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Adverse reactions

ADVERSE REACTIONS: The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria. To report SUSPECTED ADVERSE REACTIONS, contact Pharm-Olam at 1-866-511-6754 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Amcinonide appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

166 of 5,509 plans

Most common tier

Tier 4

On 77% of covering formularies

Prior authorization required

of covering formularies

Tier	Formularies on this tier	Share
Tier 1 (preferred generic)	1	8%
Tier 2 (generic)	1	8%
Tier 4 (non-preferred brand)	10	77%
Tier 5 (specialty)	1	8%

Step therapy: 0% of formularies

Quantity limits: 31% of formularies

Coverage breadth: 13 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.